Semaglutide
Research & Laboratory Information
A straightforward guide to semaglutide, its structure, GLP-1 receptor activity, published research, analytical testing and research-use material.
Semaglutide 5 mg
Research-use semaglutide material supplied as a 5 mg lyophilised vial.
View Product →What is semaglutide?
Semaglutide is a modified peptide that acts on the GLP-1 receptor. It has been widely studied in clinical research and is also used as an active pharmaceutical ingredient in authorised medicines.
Semaglutide as a peptide
A peptide is a chain of amino acids. Amino acids are the small building blocks that make up proteins and many biologically active molecules.
Semaglutide is a modified version of a peptide related to glucagon-like peptide-1, usually shortened to GLP-1.
Its structure has been modified so that it behaves differently from naturally occurring GLP-1 and remains active for much longer.
Why is semaglutide studied?
Semaglutide has been studied in areas including glucose regulation, appetite-related signalling and body-weight outcomes.
Different studies use different populations, methods, doses, endpoints and research questions. Results from one study should therefore not automatically be applied to another.
What is the GLP-1 receptor?
Understanding the receptor helps explain why semaglutide is studied and how it differs from other research peptides.
GLP-1 receptor explained
A receptor is a protein that allows a cell to respond to a particular chemical signal.
The GLP-1 receptor is found in several tissues and is involved in signalling related to glucose regulation and other biological processes.
Semaglutide and GLP-1
Semaglutide binds to and activates the GLP-1 receptor. This makes it a GLP-1 receptor agonist.
An agonist is a substance that activates a receptor and produces a biological response.
Semaglutide 5 mg for research use
TrimFast supplies semaglutide research material in a 5 mg lyophilised vial. This page explains the compound and the research information around it, while the product page provides the specific product details.
Clearly identified research material.
Product and batch information can be reviewed separately.
Intended for laboratory and analytical research only.
Semaglutide research
Semaglutide has been investigated in a wide range of research. The type of study matters when interpreting its results.
Glucose regulation
Research has examined how GLP-1 receptor activation affects glucose-related processes and markers such as blood glucose and glycated haemoglobin.
Body-weight research
Clinical studies have investigated semaglutide in people with overweight or obesity, including changes in body weight and other measured outcomes.
Appetite-related signalling
Researchers have also studied effects associated with appetite, food intake and related biological signalling.
Metabolic research
Semaglutide has been studied in wider metabolic research, including measurements linked to glucose and cardiometabolic outcomes.
Longer-term research
Some studies have followed participants for extended periods, allowing researchers to examine outcomes over time.
Analytical research
Laboratory researchers may also be interested in peptide identity, purity, concentration, stability and analytical methods.
Semaglutide in laboratory research
Research involving a peptide material can involve more than the biological question itself. Researchers may also need to understand identity, purity, concentration, stability and analytical results.
Identity
Identity testing asks whether the material matches the compound it is claimed to be.
Purity
Purity describes how much of the analysed material corresponds to the intended compound rather than other detected components.
Concentration
Concentration describes the amount of material present in a defined volume of solution.
Semaglutide molecular weight and structure
The molecular information below provides a useful starting point for researchers working with semaglutide as a peptide material.
Semaglutide
A modified peptide designed to interact with the GLP-1 receptor.
Semaglutide molecular formula
The molecular formula describes the number of atoms of each element in the molecule. For semaglutide, the commonly reported molecular formula is C187H291N45O59.
Molecular weight is the approximate mass of one mole of the compound. It is commonly expressed in grams per mole (g/mol).
Semaglutide purity, HPLC and identity testing
Different analytical tests answer different questions. Understanding the difference is important when reviewing a semaglutide COA or other laboratory report.
Semaglutide HPLC testing
HPLC stands for high-performance liquid chromatography. It separates components in a sample so they can be measured or examined.
HPLC may be used to assess chromatographic purity and identify related components.
Identity testing
Identity testing asks whether the material has characteristics consistent with the intended compound.
Mass spectrometry, often called MS, is one analytical technique that can provide information about molecular mass and identity.
Semaglutide COA
A Certificate of Analysis, or COA, is a document that reports analytical results for a particular batch or sample.
A COA is useful evidence, but it should not automatically be treated as proof that every characteristic of a material has been independently verified.
What to look for on a semaglutide COA
The report should clearly identify the material tested.
The report should be linked to a specific batch.
The testing method should be stated where applicable.
Understand exactly what the reported percentage means.
Check when the analysis was performed.
Check who performed or issued the analysis.
Semaglutide vs Tirzepatide vs Retatrutide
These compounds are related through their research into metabolic signalling, but they do not have identical receptor activity or research status.
| Compound | Receptor activity | Research status | TrimFast material |
|---|---|---|---|
| Semaglutide | GLP-1 receptor | Extensively studied | 5 mg vial → |
| Tirzepatide | GIP + GLP-1 receptors | Extensively studied | View material → |
| Retatrutide | GIP + GLP-1 + glucagon receptors | Investigational | View material → |
Want to explore the other compounds in more detail?
Published semaglutide research
The studies below provide examples of the clinical research that has contributed to understanding semaglutide. They are presented as research references, not as treatment guidance.
SUSTAIN 1
A randomised, placebo-controlled study examining once-weekly semaglutide in adults with type 2 diabetes.
View PubMed study →STEP 1
A large study examining semaglutide and body-weight outcomes in adults with overweight or obesity.
View PubMed study →Dose-ranging study
A phase 2 study examining different once-weekly semaglutide regimens in adults with obesity.
View PubMed study →Want to explore the research in more detail?
This page provides a straightforward introduction to semaglutide. The TrimFast Members Area contains deeper educational resources covering published studies, research terminology, analytical testing, COAs, preparation records and research data.
Explore Members Area →Semaglutide research questions
Straightforward answers to common questions about semaglutide, its structure and laboratory research.
What is semaglutide?
Semaglutide is a modified peptide that acts as a GLP-1 receptor agonist. It has been extensively studied in clinical research and is also used as an active pharmaceutical ingredient in authorised medicines.
What is semaglutide used to research?
Research involving semaglutide has examined areas including glucose regulation, appetite-related signalling, body-weight outcomes and wider metabolic measures.
What is the molecular weight of semaglutide?
The commonly reported molecular weight of semaglutide is approximately 4,114 g/mol.
What is the molecular formula of semaglutide?
The molecular formula commonly reported for semaglutide is C187H291N45O59.
What is a semaglutide COA?
A Certificate of Analysis, or COA, reports analytical results for a particular batch or sample. Depending on the laboratory and material, it may include identity, purity, assay and other analytical results.
How is semaglutide purity tested?
Chromatographic methods such as HPLC can be used to examine the composition of a sample and assess chromatographic purity. Other analytical methods can provide different information, such as molecular identity.
What is the difference between semaglutide and tirzepatide?
Semaglutide primarily activates the GLP-1 receptor, while tirzepatide acts on both the GIP and GLP-1 receptors. The two compounds therefore have different receptor activity.
Is semaglutide research material the same as a medicine?
No. Research-use material supplied by TrimFast is not presented as an authorised medicine or as a product for human or veterinary administration. Research material and authorised pharmaceutical products should not be treated as interchangeable.
Looking for Semaglutide 5 mg?
Explore the TrimFast Semaglutide 5 mg product page for product, batch and research-use information.
View Semaglutide 5 mg →